Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Guggenheim Securities
Entity

Guggenheim Securities

Tracked across 2 events · 18 articles · First seen Apr 01, 2026 · Last active Apr 09, 2026

Sentiment
10
Attention
4
Events
2
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 10
Business
Forte Biosciences Prices $150M Public Offering
Guggenheim Securities is acting as a book-running manager for Forte Biosciences' public offering, facilitating the sale of shares and managing the offering process.
Apr 08, 2026 · 7 articles
4 10
Business
Celldex Therapeutics Closes $345M Public Offering
Guggenheim Securities was a joint bookrunning manager for Celldex Therapeutics' public offering, playing a key role in the transaction.
Apr 01, 2026 · 11 articles
Key Actions (1)
70 Guggenheim Securities Acted as book-running manager for the offering Forte BiosciencesForte Biosciences Prices...
Relationships (1)
Forte Biosciences client ↔ Guggenheim Securities Forte Biosciences is a client of Guggenheim Securities for its public offering.
NEWSDESK
Track Guggenheim Securities live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.